Effects of Binaural Beats on Inhaled Anesthetic Requirements During General Anesthesia in Pediatric Patients
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · May 11, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether listening to binaural beats—sounds that can help create a calming effect—during surgery can reduce the amount of a common anesthetic called sevoflurane needed for children. Researchers believe that by providing these special sounds while the child is under general anesthesia, they might need less medication to stay asleep and comfortable during their procedure. The trial will compare two groups of young patients: one group will listen to binaural beats during surgery, and the other group will not.
To participate in this study, children must be under 3 years old and scheduled for certain types of surgeries that last more than an hour. They should be generally healthy, classified as ASA physical status I or II, which means they have no serious health issues. However, children who are newborns, have hearing problems, or certain other medical conditions will not be eligible. The trial is not yet recruiting participants, but once it starts, parents can expect their child to be carefully monitored throughout the process to ensure safety and comfort.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Pediatric patients under 3 years of age undergoing superficial surgery lasting more than 1 hour under general anesthesia (e.g., nevus excision, polydactyly/syndactyly surgery, dermoid cyst excision, thyroglossal duct cyst excision, preauricular fistula excision, inguinal hernia repair, orchiopexy, other mass excisions, strabismus surgery, etc.).
- • 2. American Society of Anesthesiologists (ASA) physical status classification I or II.
- Exclusion Criteria:
- • Neonates or premature infants
- • Children with hearing impairment or currently using hearing aids
- • Children with neurological disorders
- • Children with respiratory diseases
- • Children undergoing neurosurgery or cardiac surgery
- • Other patients deemed inappropriate for inclusion in the clinical trial at the discretion of the investigator or study staff
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported